eurobio

Boditech 1

WERFEN 2

WERFEN

gene edting

Gene editing DNA deletion sizes reduced with new fusion method

Wake Forest Institute for Regenerative Medicine (WFIRM) scientists working on CRISPR/Cas9-mediated gene editing technology have developed a method to increase efficiency of editing while minimizing DNA deletion sizes, a key step toward developing gene editing therapies to treat genetic diseases.

HKU lab

Researchers discover new molecular mechanism in promoting melanoma angiogenesis and metastasis

A research team at LKS Faculty of Medicine, The University of Hong Kong (HKUMed) has discovered a new molecular pathway to govern melanoma angiogenesis and metastasis. The findings provide new insights into how melanoma undergoes metastasis and progression through secretion of pro-angiogenic factor to induce angiogenesis that paves the way for new therapeutic opportunities. The […]

thermofisher electroporation

Thermo Fisher’s new customizable CTS Xenon Electroporation System enables large-scale cell therapy development and clinical manufacturing

Thermo Fisher Scientific has introduced a new large-volume electroporation system that allows cell therapy developers to more easily move from clinical development to commercial manufacturing. The Gibco CTS Xenon Electroporation System leverages a closed, highly flexible design to facilitate gene modifications without the use of traditional viral vectors. The electroporation approach enables the introduction of […]

Shimadzu runner

Shimadzu to showcase range of lab solutions at analytica in Munich

Shimadzu, one of the world leaders in analytical instrumentation, will present its range of laboratory solutions from chroma-tography, spectroscopy, spectrometry, TOC, material testing to system software at analytica from June 21–24, 2022 in Munich. The company will also launch a number of products on the European market. 

CN Bio PhysioMimix

CN Bio introduces PhysioMimix NASH ‘in-a-box’ reagent kit

CN Bio, a leading organ-on-a-chip company (OOC) that designs and manufactures single- and multi-organ microphysiological systems (MPS), has introduced its Physio-Mimix ‘in-a-box’ reagent kit for non-alcoholic steatohepatitis (NASH), the most severe form of non-alcoholic fatty liver disease (NAFLD). Previously only accessible via its contract research services, CN Bio’s best-in-class NASH in vitro model supports the urgent […]

amsbiopr313

AMSBIO isolates and provides high purity exosomes

AMSBIO is a leading supplier of high purity exosomes using isolation methods including traditional differential and gradient ultracentrifugation, immunoaffinity, size exclusion chromatography as well as precipitation / low speed centrifugation.